Literature DB >> 15629498

Angiogenesis and chronic inflammation; the potential for novel therapeutic approaches in chronic liver disease.

W K Lai, David H Adams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629498     DOI: 10.1016/j.jhep.2004.11.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  15 in total

1.  Structure of calcium-bound human S100A13 at pH 7.5 at 1.8 A resolution.

Authors:  Fabiana Lica Imai; Koji Nagata; Naoto Yonezawa; Minoru Nakano; Masaru Tanokura
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-01-31

2.  Angiogenesis: a phenomenon which aggravates chronic liver disease progression.

Authors:  Michał Kukla
Journal:  Hepatol Int       Date:  2012-07-26       Impact factor: 6.047

3.  Regulation of endothelial glutathione by ICAM-1 governs VEGF-A-mediated eNOS activity and angiogenesis.

Authors:  Will Langston; John H Chidlow; Blake A Booth; Shayne C Barlow; David J Lefer; Rakesh P Patel; Christopher G Kevil
Journal:  Free Radic Biol Med       Date:  2006-12-16       Impact factor: 7.376

4.  The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea.

Authors:  M A Aller; I Prieto; S Argudo; F de Vicente; L Santamaría; M P de Miguel; J L Arias; J Arias
Journal:  Int J Inflam       Date:  2010-10-05

5.  Thrombospondin-1 expression correlates with angiogenesis in experimental cirrhosis.

Authors:  Gulsum-Ozlem Elpek; Guzide-Ayse Gokhan; Sevgi Bozova
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

Review 6.  Apoptosis and angiogenesis: an evolving mechanism for fibrosis.

Authors:  Ariel Johnson; Luisa Ann DiPietro
Journal:  FASEB J       Date:  2013-06-19       Impact factor: 5.191

7.  Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells.

Authors:  Yangqing Huang; Helin Feng; Tong Kan; Bin Huang; Minfeng Zhang; Yesheng Li; Changying Shi; Mengchao Wu; Yunquan Luo; Jiamei Yang; Feng Xu
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

8.  Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population.

Authors:  Neneng Ratnasari; Siti Nurdjanah; Ahmad Hamim Sadewa; Mohammad Hakimi; Yoshihiko Yano
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

9.  Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease.

Authors:  Maria-Vasiliki Papageorgiou; Emilia Hadziyannis; Dina Tiniakos; Anastasia Georgiou; Aikaterini Margariti; Athanasios Kostas; George V Papatheodoridis
Journal:  Ann Gastroenterol       Date:  2016-12-01

10.  Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice.

Authors:  Ling-Jian Kong; Hao Li; Ya-Ju Du; Feng-Hua Pei; Ying Hu; Liao-Liao Zhao; Jing Chen
Journal:  Mol Med Rep       Date:  2017-03-15       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.